Wall Street Experts
ver. ZuMIgo(08/25)
CG Oncology, Inc. Common stock
Rachunek Zysków i Strat
Przychody TTM (mln): 1
EBIT TTM (mln): -96
| index |
0 |
1 |
2 |
3 |
| Rok finansowy |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
10 |
0 |
0 |
1 |
| Przychód Δ r/r |
0.0% |
-98.2% |
6.8% |
458.3% |
| Marża brutto |
99.9% |
92.1% |
100.0% |
100.0% |
| EBIT (mln) |
-13 |
-35 |
-55 |
-115 |
| EBIT Δ r/r |
0.0% |
179.6% |
57.3% |
106.8% |
| EBIT (%) |
-121.7% |
-18453.4% |
-27180.9% |
-10067.3% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
| EBITDA (mln) |
-12 |
-35 |
-55 |
-115 |
| EBITDA(%) |
-121.6% |
-18445.5% |
-27172.5% |
-10067.3% |
| Podatek (mln) |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-13 |
-35 |
-49 |
-88 |
| Zysk netto Δ r/r |
0.0% |
176.1% |
37.1% |
81.1% |
| Zysk netto (%) |
-124.0% |
-18556.5% |
-23827.0% |
-7729.5% |
| EPS |
-0.19 |
-0.53 |
-15.65 |
-1.41 |
| EPS (rozwodnione) |
-0.19 |
-0.53 |
-15.65 |
-1.41 |
| Ilośc akcji (mln) |
67 |
67 |
4 |
62 |
| Ważona ilośc akcji (mln) |
67 |
67 |
4 |
62 |
| Waluta |
USD |
USD |
USD |
USD |